Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Children’s National Team Alerts FDA to Improper Antibiotics Sales
  • USA - English


News provided by

Children's National Health System

Mar 03, 2014, 15:00 ET

Share this article

Share toX

Share this article

Share toX

Washington, DC (PRWEB) March 03, 2014 -- Scott A. Norton, MD, MPH, chief of dermatology at Children’s National Health System, and two medical students working with him identified improper sales of antibiotics without prescriptions in neighborhood grocery stores in the Washington, DC, area. Their work prompted the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention to warn consumers about the drugs.

The medications can have serious side effects that can cause serious skin disorders or have life-threatening adverse reactions.

Beginning in August, 2012, Dr. Norton and his staff investigated the availability of several cold remedies made in El Salvador and illegally imported into the United States. These products, such as Baczol Antigripol and Baczol Expectorante, include a sulfonamide-containing antibiotic, trimethoprim-sulfamethoxazole (TMP-SMX), which is a well-known cause of fixed drug eruption and other serious side effects. The products were labeled in Spanish only and marketed to treat bronchitis, sinusitis, pharyngitis, and other respiratory infections.

In particular, Dr. Norton and his team identified sales of the medications in Latino neighborhood stores and then alerted the FDA, which issued alerts on Aug. 20, 2013 in English and Spanish about illegal sales of prescription antibiotics sold as over-the-counter cold remedies.

TMP/SMX-containing products were found in three of seven stores in Latino neighborhoods in Washington, DC, one of six stores in Virginia and three of six stores in Maryland. Dr. Norton is concerned that such sales are continuing.

“Although the particular condition that our patients had, fixed drug eruption, is fairly minor, the children developed large blisters every time they took these medications– and the blisters were on the same sites on the skin each time,” Dr. Norton says. “The sores are painful while they are active and can leave permanent discolorations on the skin. The families and their physicians did not recognize the cause of the eruption and one family was referred to Child Protective Services to make sure there wasn’t physical abuse in the home.”

Dr. Norton’s awareness of the illegal Baczol products began in 2012, when a 7-year-old Salvadoran-American boy developed three slightly painful, well-demarcated, flat gray-brown patches on his torso. In June, 2013, another Salvadoran-American child, a 14-year-old girl who resided in Northern Virginia, was evaluated for a similar condition “likely caused by a Baczol product purchased near her home,” according to a CDC report in November 2013.

“The particular condition, fixed drug eruption, is uncommon, but the presence of the medication in the stores shows that more awareness is necessary,” Dr. Norton says. “I’m particularly concerned that the illegal products may have caused more serious, perhaps life-threatening, side effects – and that no one has been able to determine why these kids became so ill.”

The labels on the cold remedies included the phrase “venta únicamente en El Salvador” [“for sale only in El Salvador”] but were, nevertheless, on shelves of many stores in the DC area. Consumers who have purchased either product should immediately stop taking it and consult a health care professional.

TMP/SMX is an important and widely used antibiotic but it is a known cause of fixed drug eruptions and other adverse drug reactions and can be dispensed in the U.S. only with a prescription. These ingredients can cause serious, and even life-threatening, adverse reactions in some patients, including kidney and liver failure, blood cell abnormalities, and painful skin reactions.

Baczol products are manufactured by Laboratorios López, a company located in El Salvador.

There is at least one product, also sold under the name Baczol Antigripal, which contains no antibiotics and is imported legally into the United States and sold legally without a prescription. The legal, antibiotic-free product contains ingredients that are similar to those of dozens of over-the-counter cough and cold remedies widely available throughout the US. The boxes of the two Antigripal products, the one allegedly illegally imported with TMP-SMX, and the legally imported one without antibiotics, are nearly identical, Norton says.

In carrying out the investigation, Norton and the two medical students who were working with him used U.S. Census data to identify heavily Salvadoran neighborhoods in the Washington, DC, area and then searched the Internet for Latino grocery stores in those neighborhoods.

The other investigators are Christine C. Yang, State University of New York Upstate Medical University, and Audrey N. Green, Mercer University School of Medicine in Georgia.

“After the medical students who helped me finished their rotation and left Washington, DC, they checked in other communities and are finding the illegal products for sale in Latino groceries all over the country, in Washington state, Massachusetts, California, and Texas,” Dr. Norton says.

Contact: Emily Hartman or Joe Cantlupe, 202-476-4500

About Children’s National Health System
Children’s National Health System, based in Washington, DC, has been serving the nation’s children since 1870. Children’s National’s hospital is Magnet® designated, and is consistently ranked among the top pediatric hospitals by U.S.News & World Report. Home to the Children’s Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children’s National is one of the nation’s top NIH-funded pediatric institutions. With a community-based pediatric network, eight regional outpatient centers, an ambulatory surgery center, two emergency rooms, an acute care hospital, and collaborations throughout the region, Children’s National is recognized for its expertise and innovation in pediatric care and as an advocate for all children. For more information, visit ChildrensNational.org, or follow us on Facebook and Twitter.

Caitlyn Camacho, Children's National Health System, +1 301-244-6737, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.